About US
Contact us
-
Winston submits NDA for CIVANEX to U.S. FDAWinston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. ("Winston") (OTC PINK: WPHM), a pharmaceutical company focused on developing and commercializing novel pain man2010/7/8
-
Three Rivers Pharmaceuticals receives FDA expanded labeling for INFERGENThree Rivers Pharmaceuticals, LLC, today received expanded labeling from the U.S. Food and Drug Administration (FDA) to include daily use of INFERGEN (Consensus Interferon) in combination with ribav2010/7/7
-
Bacterin International Obtains ISO CertificationBELGRADE, MONTANA, MARCH 29, 2010 --- Bacterin International, Inc. (Bacterin), a medical device and biologics manufacturing company, is pleased to announce it has received certification from the Inter2010/7/7
-
Bayer's CONTOUR USB Blood Glucose Meter Wins Medical Design Excellence AwardTARRYTOWN, NY, JUNE 9, 2010 --- Bayer's CONTOUR(R) USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excelle2010/7/7
-
Re-inventing the color orangeNew BASF pigment for high-performance plastics Presentation by Mario Dittes Technical Center Plastic Additives BASF SE, Ludwigshafen, Germany The color orange has a cheerful and refreshing, wa2010/7/6
-
Intellipharmaceutics provides update on generic version of Effexor XRIntellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced the following with regard to its generic drug commercialization activities. Wyeth LLC, a wholly owned subsidiary of Pf2010/7/6
-
Watson Laboratories receives FDA approval for Tacrolimus ANDAWatson Pharmaceuticals, Inc. (NYSE: WPI), today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated2010/7/6
-
Studies demonstrate analgesic properties of synthetic cannabinoidA new compound similar to the active component of marijuana (cannabis) might provide effective pain relief without the mental and physical side effects of cannabis, according to a study in the July2010/7/5
-
Strativa receives FDA approval for Zuplenz oral soluble filmStrativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and mo2010/7/5
-
Easy flowingUltramid family with improved flow behavior now complete Presentation by Dr. Anka Bernnat Product Development Automotive Engineering Plastics Europe BASF SE, Ludwigshafen, Germany With any th2010/7/2